ADP-Ribosyl Cyclase as a Therapeutic Target for Central Nervous System Diseases

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 3, 2006-09 ,pp. : 193-210

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of neuropeptide Y in central nervous system disorders with special reference to pain and sympathetically maintained pain

By Cougnon N.   Hudspith M.   Munglani R.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 6, 1997-06 ,pp. : 759-770

Informa Healthcare

Access to resources Recommend Favorite

The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 22, 2011-07 ,pp. : 2264-2277

Bentham Science Publishers

Access to resources Recommend Favorite

Histamine in Immune Regulation: Possible Roles in Autoimmune Demyelinating Disease of the Central Nervous System

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 6, 2005-12 ,pp. : 637-643

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: New Therapeutic Options in Central Nervous System Involvement of Rheumatologic Diseases (Executive Editor: Ali Gur)]

By  

Current Pharmaceutical Design, Vol. 14, Iss. 13, 2008-05 ,pp. : 1240-1241

Bentham Science Publishers

Access to resources Recommend Favorite